🇺🇸 FDA
Patent

US 10918738

Method of treating type I diabetes using an AAV vector encoding uracortin 2

granted A61KA61K31/436A61K31/65

Quick answer

US patent 10918738 (Method of treating type I diabetes using an AAV vector encoding uracortin 2) held by The Regents of the University of California expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/436, A61K31/65, A61K38/2221, A61K38/2228